{"database": "lobbying", "table": "lobbying_activities", "rows": [[1515883, "2b395064-06f3-4fc7-a4f8-42411e51bb57", "Q1", "DELAHUNT GROUP, LLC", 401066001, "HEALIANCE PHARMACEUTICALS", 2014, "first_quarter", "FOR", "innovative diabetes treatment", "HOUSE OF REPRESENTATIVES,Natl Security Agency (NSA),SENATE,State, Dept of (DOS),Treasury, Dept of", 0, 0, "2014-04-14T23:57:17.060000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1515883"], "units": {}, "query_ms": 1607.8768610022962, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}